- call +1-201-465-4211
- email sales@mrinsights.biz
Placement of these bioresorbable devices enable individuals to live with a normal functioning artery as well as the option to undergo an angioplasty in their later years. While still in development stage, the pediatric patient cohort with genetic coronary conditions are a viable target for these fully dissolvable stents that allow restoration of normal vasomotor function as well as normal vessel growth.
Scope of the Report:
This report studies the Bioresorbable Coronary Stents market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Bioresorbable Coronary Stents market by product type and applications/end industries.
APAC is expected to witness the fastest growth with a CAGR of 21%. Apart from increasing coronary stenting procedure volumes that stem from the high CVD-afflicted patient count, this region witnesses quick uptake of CE and FDA-approved devices, which in turn is engendering the high sales revenue of bioresorbable coronary stents in this regional segment.
The global Bioresorbable Coronary Stents market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Bioresorbable Coronary Stents.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
BIOTRONIK
Meril Lifesciences Pvt. Ltd.
Elixir Medical Corporation
REVA Medical
Arterial Remodeling Technologies
Amaranth Medical
Microport Scientific Corporation
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Absorb BVS
Absorb 2nd Generation
Magmaris
Magnitude
MeRes-100
DESolve
Market Segment by Applications, can be divided into
Hospital
Clinic
Research Institute
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Bioresorbable Coronary Stents Market Overview
1.1 Product Overview and Scope of Bioresorbable Coronary Stents
1.2 Classification of Bioresorbable Coronary Stents by Types
1.2.1 Global Bioresorbable Coronary Stents Revenue Comparison by Types (2017-2023)
1.2.2 Global Bioresorbable Coronary Stents Revenue Market Share by Types in 2017
1.2.3 Absorb BVS
1.2.4 Absorb 2nd Generation
1.2.5 Magmaris
1.2.6 Magnitude
1.2.7 MeRes-100
1.2.8 DESolve
1.3 Global Bioresorbable Coronary Stents Market by Application
1.3.1 Global Bioresorbable Coronary Stents Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.4 Global Bioresorbable Coronary Stents Market by Regions
1.4.1 Global Bioresorbable Coronary Stents Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Bioresorbable Coronary Stents Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Bioresorbable Coronary Stents Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bioresorbable Coronary Stents Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Bioresorbable Coronary Stents Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bioresorbable Coronary Stents Status and Prospect (2013-2023)
1.5 Global Market Size of Bioresorbable Coronary Stents (2013-2023)
2 Manufacturers Profiles
2.1 BIOTRONIK
2.1.1 Business Overview
2.1.2 Bioresorbable Coronary Stents Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 BIOTRONIK Bioresorbable Coronary Stents Revenue, Gross Margin and Market Share (2016-2017)
2.2 Meril Lifesciences Pvt. Ltd.
2.2.1 Business Overview
2.2.2 Bioresorbable Coronary Stents Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Meril Lifesciences Pvt. Ltd. Bioresorbable Coronary Stents Revenue, Gross Margin and Market Share (2016-2017)
2.3 Elixir Medical Corporation
2.3.1 Business Overview
2.3.2 Bioresorbable Coronary Stents Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Elixir Medical Corporation Bioresorbable Coronary Stents Revenue, Gross Margin and Market Share (2016-2017)
2.4 REVA Medical
2.4.1 Business Overview
2.4.2 Bioresorbable Coronary Stents Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 REVA Medical Bioresorbable Coronary Stents Revenue, Gross Margin and Market Share (2016-2017)
2.5 Arterial Remodeling Technologies
2.5.1 Business Overview
2.5.2 Bioresorbable Coronary Stents Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Arterial Remodeling Technologies Bioresorbable Coronary Stents Revenue, Gross Margin and Market Share (2016-2017)
2.6 Amaranth Medical
2.6.1 Business Overview
2.6.2 Bioresorbable Coronary Stents Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Amaranth Medical Bioresorbable Coronary Stents Revenue, Gross Margin and Market Share (2016-2017)
2.7 Microport Scientific Corporation
2.7.1 Business Overview
2.7.2 Bioresorbable Coronary Stents Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Microport Scientific Corporation Bioresorbable Coronary Stents Revenue, Gross Margin and Market Share (2016-2017)
3 Global Bioresorbable Coronary Stents Market Competition, by Players
3.1 Global Bioresorbable Coronary Stents Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Bioresorbable Coronary Stents Players Market Share
3.2.2 Top 10 Bioresorbable Coronary Stents Players Market Share
3.3 Market Competition Trend
4 Global Bioresorbable Coronary Stents Market Size by Regions
4.1 Global Bioresorbable Coronary Stents Revenue and Market Share by Regions
4.2 North America Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
4.3 Europe Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
4.5 South America Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
5 North America Bioresorbable Coronary Stents Revenue by Countries
5.1 North America Bioresorbable Coronary Stents Revenue by Countries (2013-2018)
5.2 USA Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
5.3 Canada Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
5.4 Mexico Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
6 Europe Bioresorbable Coronary Stents Revenue by Countries
6.1 Europe Bioresorbable Coronary Stents Revenue by Countries (2013-2018)
6.2 Germany Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
6.3 UK Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
6.4 France Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
6.5 Russia Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
6.6 Italy Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Bioresorbable Coronary Stents Revenue by Countries
7.1 Asia-Pacific Bioresorbable Coronary Stents Revenue by Countries (2013-2018)
7.2 China Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
7.3 Japan Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
7.4 Korea Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
7.5 India Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
8 South America Bioresorbable Coronary Stents Revenue by Countries
8.1 South America Bioresorbable Coronary Stents Revenue by Countries (2013-2018)
8.2 Brazil Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
8.3 Argentina Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
8.4 Colombia Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Bioresorbable Coronary Stents by Countries
9.1 Middle East and Africa Bioresorbable Coronary Stents Revenue by Countries (2013-2018)
9.2 Saudi Arabia Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
9.3 UAE Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
9.4 Egypt Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
9.5 Nigeria Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
9.6 South Africa Bioresorbable Coronary Stents Revenue and Growth Rate (2013-2018)
10 Global Bioresorbable Coronary Stents Market Segment by Type
10.1 Global Bioresorbable Coronary Stents Revenue and Market Share by Type (2013-2018)
10.2 Global Bioresorbable Coronary Stents Market Forecast by Type (2018-2023)
10.3 Absorb BVS Revenue Growth Rate (2013-2023)
10.4 Absorb 2nd Generation Revenue Growth Rate (2013-2023)
10.5 Magmaris Revenue Growth Rate (2013-2023)
10.6 Magnitude Revenue Growth Rate (2013-2023)
10.7 MeRes-100 Revenue Growth Rate (2013-2023)
10.8 DESolve Revenue Growth Rate (2013-2023)
11 Global Bioresorbable Coronary Stents Market Segment by Application
11.1 Global Bioresorbable Coronary Stents Revenue Market Share by Application (2013-2018)
11.2 Bioresorbable Coronary Stents Market Forecast by Application (2018-2023)
11.3 Hospital Revenue Growth (2013-2018)
11.4 Clinic Revenue Growth (2013-2018)
11.5 Research Institute Revenue Growth (2013-2018)
12 Global Bioresorbable Coronary Stents Market Size Forecast (2018-2023)
12.1 Global Bioresorbable Coronary Stents Market Size Forecast (2018-2023)
12.2 Global Bioresorbable Coronary Stents Market Forecast by Regions (2018-2023)
12.3 North America Bioresorbable Coronary Stents Revenue Market Forecast (2018-2023)
12.4 Europe Bioresorbable Coronary Stents Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Bioresorbable Coronary Stents Revenue Market Forecast (2018-2023)
12.6 South America Bioresorbable Coronary Stents Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Bioresorbable Coronary Stents Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Bioresorbable Coronary Stents Picture
Table Product Specifications of Bioresorbable Coronary Stents
Table Global Bioresorbable Coronary Stents and Revenue (Million U
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
